Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy

Phase 3CompletedNCT01915550

Ain Shams University90 enrolled

Overview

Adding metformin to insulin therapy in pregnant women with diabetes mellitus who show insulin resistance may be equivalently effective to further raising the insulin dose

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Diabetes Mellitus

Interventions

MetforminDRUG

Humulin Insulin MixtardDRUG

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * pregnant women with insulin-resistant diabetes mellitus Exclusion Criteria: * type-1 diabetes mellitus * secondary diabetes mellitus

Locations (1)

Ain Shams University Maternity Hospital

Cairo, Cairo Governorate, Egypt

Outcomes

Primary Outcomes

Proper Glycemic Control

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.